Hematopoietic cell transplantation (HCT) recipients and their caregivers should be educated regarding strategies to avoid environmental exposure to opportunistic pathogens (AIII).
Preventing infections primarily transmitted by direct contact
Hematopoietic cell transplantation recipients and candidates should maintain frequent and consistent hand hygiene (AII), especially related to the following:
Before eating or preparing food. After changing diapers. After touching plants or dirt. After urinating or defecating. After touching animals. After touching body fluids or excretions or items that might have had contact with human or animal feces (for example, clothing, bedding, toilets or bedpans). After going outdoors or to a public place. After removing gloves. After collecting or depositing garbage. Before and after touching catheters or wounds. 579 Conscientious hand hygiene using an alcohol-based hand gel or soap and water is especially critical during the first 6 months after HCT and during other periods of substantial immunosuppression (for example, treatment of GVHD, systemic steroid use or relapse of the underlying disease for which the transplant was performed). Pediatric HCT recipients and candidates should be supervised by adults during hand disinfection to ensure thorough cleaning. Hand hygiene should be maintained with an alcohol-based hand gel or with soap and water (AII). 703, 704 HCT recipients who visit or live on farms should follow published recommendations for preventing cryptosporidiosis. 705, 706 Hematopoietic cell transplantation recipients should avoid changing diapers whenever possible (BIII). Even if gloves are worn, hands should always be washed after gloves are removed, as gloves may have defects that are not easily visible (AIII). 707, 708 Preventing infections primarily transmitted through respiratory exposures Community-acquired respiratory viral infections can cause severe disease and mortality in HCT recipients. 709 To prevent respiratory infections after hospital discharge, HCT recipients should observe the following precautions:
Maintain frequent and thorough hand hygiene (BIII), and avoid touching their eyes, nose and mouth unless they have disinfected their hands to avoid inoculating themselves with community-acquired respiratory virus. Avoid close contact with persons with respiratory illnesses (BIII). When close contact is unavoidable, both the HCT recipient and the symptomatic contact should be encouraged to disinfect their hands frequently, as this has been shown to reduce the transmission of respiratory and other illnesses. [710] [711] [712] [713] Symptomatic contacts should also consider wearing surgical masks 714 or, at a minimum, cover their mouth and nose with a disposable tissue when sneezing or coughing 715 or, if tissues are not available, using their upper sleeves. 603 Although HCT recipients can wear masks themselves when in contact with symptomatic persons, the degree of protection from wearing masks has not been determined. Maintain particularly careful hand hygiene when in crowded areas (for example, shopping malls or public elevators) where close contact with persons with respiratory illnesses is likely, especially during autumn and winter months (AII).
Visitors to HCT centers can introduce communicable infections through environmental contamination or direct spread. All visitors should maintain hand hygiene before and after visits. All visitors should be screened for symptoms of infection, such as fever, rash, vomiting, diarrhea, upper respiratory symptoms or conjunctivitis, and should not be allowed to visit an HCT recipient while they are symptomatic (BIII).
Hematopoietic cell transplantation recipients and candidates undergoing conditioning therapy are also at risk for infections caused by fungal, parasitic and bacterial pathogens associated with exposure to soil, plants or their aerosols (for example, Toxoplasma gondii, Histoplasma capsulatum, Cryptococcus neoformans, Nocardia species and Aspergillus species). To prevent such infections, HCT recipients and candidates should follow the following precautions:
During the first 6 months after HCT and during periods of substantial immunosuppression (for example, treatment for GVHD, systemic steroid use or relapse of the underlying disease for which the transplant was performed), HCT recipients and candidates who are undergoing conditioning therapy should avoid gardening or direct contact with soil, plants or their aerosols (BIII). If such activity is unavoidable, these individuals should wear protective gloves to prevent abrasions or lacerations, and surgical or N95 masks while touching plants or soil, although the effectiveness of gloves and masks to protect against infections associated with exposure to soil is unknown.
716-721 HCT recipients should avoid creating plant or soil aerosols through activities such as spreading mulch.
722,723 HCT recipients should always thoroughly wash their hands with soap and water after soil or plant contact. HCT recipients should avoid construction or excavation sites or other dust-laden environments for the first 6 months after HCT and during other periods of substantial immunosuppression to avoid exposures to molds.
724 Outpatient HCT recipients should be advised of travel routes to the HCT center that will avoid or minimize exposure to construction sites (CIII).
Coccidioidomycosis is uncommon after allogeneic HCT but can present as a severe disease. 725, 726 HCT recipients traveling to or residing in areas in which coccidioidomycosis is endemic (for example, the American Southwest, Mexico, and Central and South America) should avoid activities that cause exposure to dust 727 and should minimize exposure to dust or disturbed soil, including construction or excavation sites, areas that experienced recent earthquakes, farms or other rural areas (CIII). Histoplasmosis (H. capsulatum infection) after allogeneic HCT is also rare. However, HCT recipients in histoplasmosis-endemic areas should avoid exposure to bird-roosting sites and caves 728 and should avoid exposure to bird or bat droppings (CIII). 729, 730 Hematopoietic cell transplantation candidates or recipients should be advised that certain activities and occupations (for example, work in health-care settings, prisons, jails or homeless shelters) can increase their risk for TB exposure. 731, 732 In deciding whether an HCT recipient should continue activities in these settings, physicians should evaluate the patient's specific duties, the precautions used to prevent TB exposure in the workplace and the prevalence of TB in the community. The decision to continue or terminate such activities should be made jointly between patient and physician. HCT recipients should avoid exposure to persons with active TB, particularly during the first 6 months after HCT and during other periods of substantial immunosuppression (BIII).
Persons whose occupations involve animal contact (for example, veterinarians, pet store employees, farmers or slaughterhouse workers) may be at increased risk for toxoplasmosis, Q fever, brucellosis and other zoonotic diseases. Although data are insufficient to justify a general recommendation against HCT recipients working in such settings, these exposures should be avoided during the first 6 months after HCT and during other periods of substantial immunosuppression (BIII).
Hematopoietic cell transplantation recipients should exercise caution when handling household trash. Air surrounding solid waste has been shown to contain culturable, aerosolized bacteria and fungi. 733 Although there have been no cases of infection definitively linked to routine handling of solid waste, it is recommended that HCT recipients wear masks and use gloves when handling substantial volumes of waste (CIII).
Recommendations regarding household members who receive live-attenuated vaccines
Household members should receive recommended vaccines to prevent illness in the household and reduce the risk of transmission of infections to the HCT recipient (Table 6) . When a choice between a live-attenuated vaccine and an inactivated vaccine exists (for example, influenza, polio), household members should receive inactivated vaccine to reduce the potential risk of transmission of the vaccine virus. To ensure that HCT patients are optimally protected from vaccine-preventable diseases through vaccination of household contacts while minimizing the risk of transmission of vaccine virus, clinicians should consider the following data and current recommendations:
Polio vaccine (AII): Household members of HCT recipients should receive inactivated polio vaccine, as oral polio vaccine is a live-attenuated vaccine that has been rarely associated with paralysis in healthy recipients and their contacts. If oral polio vaccine vaccine is inadvertently administered to a household contact, close contact should be avoided for approximately 4-6 weeks after vaccination (AII). If this is not feasible, HCT recipients should maintain careful hand hygiene after Thus, routine standard precautions are currently recommended for recently immunized infants. To minimize the risk of potential vaccine virus transmission, HCT recipients should avoid handling diapers if possible. If this is not feasible, HCT recipients should perform careful hand hygiene maintenance procedures after any contact with feces from the vaccinated household member (AIII). Until further data on the risks of transmission of vaccine virus become available, HCT units may wish to exclude infants who recently received rotavirus vaccine from visiting for 2-4 weeks after receiving a vaccine dose (CIII). Live-attenuated influenza vaccine: Studies have shown that 80% of vaccine recipients 8-36 months of age shed one or more vaccine virus strains for a mean duration of 7.6 days. Thus far, there have not been any documented cases of transmission to an immunocompromised host and only one case of documented transmission has occurred in an immunocompetent host, with an estimated transmission rate of 0.6-2.9% in a population of young children enrolled in a child-care center. 740 In adults, shedding mostly occurs within the first 3 days, but can continue for as long as 7 days after vaccination.
740,741
In HIV-infected individuals, who had a CDC (Centers for Disease Control) class of A1-2 and a plasma HIV RNA count o10,000 and CD4 count 4200, none shed live-attenuated influenza vaccine virus for more than 10 days. Furthermore, clinical trial data suggest that when vaccine virus is shed by vaccine recipients, none reverted to wild type. 742, 743 As an alternative trivalent inactivated influenza vaccine exists, household members of HCT recipients should receive trivalent inactivated influenza vaccine to avoid potential concerns for transmission of vaccine virus (AI). Health-care center personnel and HCT center visitors who receive liveattenuated influenza vaccine instead of trivalent inactivated influenza vaccine should avoid contact with severely immunosuppressed persons for 7 days after vaccination (CIII).
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Zoster vaccine: The herpes zoster vaccine is currently recommended for adults 60 years of age or older in the United States. 744 There is no evidence to date that transmission of vaccine-associated virus has occurred. However, HCT centers should exclude visitors who develop a varicella-or zoster-like rash after vaccination (AIII). If a household member develops a varicella-or zoster-like rash after vaccination, close contact with the HCT recipient should be avoided and affected areas should be covered (AIII).
Varicella vaccine (AIII):
In one small study of 37 healthy children receiving vaccine and their 30 immunocompromised siblings, there was no evidence of vaccine virus transmission. 745 In the postlicensure era, transmission from immunocompetent persons after vaccination has been documented by PCR from only five persons resulting in six secondary infections, with over 55 million doses estimated to have been given. 282 As the risk of vaccine virus transmission is low, particularly in the absence of a vaccine-associated rash, household members should receive varicella vaccine to protect HCT recipients from potential exposure to wild-type disease (AIII). Individuals who experience a vaccine-associated rash within 1 month after varicella vaccination should be excluded from visiting the HCT center and should avoid close contact with HCT recipients in the home setting (BIII). Measures such as removal of the vaccinee or transplant recipient from the domicile have not been studied. Measles, mumps, rubella vaccine (AIII): Household members should receive age-appropriate measles, mumps, rubella vaccination as recommended. However, vaccine recipients who develop a fever and/or rash after vaccination should be excluded from visiting the HCT center while symptomatic and should avoid close contact with HCT recipients in the home setting (BIII).
Safe sex
Sexually active patients who are not in long-term monogamous relationships should always use latex condoms during sexual contact to reduce their risk of exposure to CMV, HSV, HIV, HPV, HBV, HCV and other sexually transmitted infections (AII). However, even long-time monogamous partners can be discordant for these infections. Reinfection with some sexually transmitted infections has been reported in seropositive recipients with long-term partners years after transplant.
370 Therefore, sexually active HCT recipients in long-term monogamous relationships should consider using latex condoms during sexual contact to reduce their risk of exposure to these sexually transmitted infections (CIII). In addition, contact with oral or genital secretions has been associated with the acquisition of many sexually transmitted infections, including those from HSV, CMV, EBV, HHV-8 and HPV. Severely immunosuppressed HCT recipients should consider completely avoiding unprotected sexual activity (that is, activities that involve contact of the HCT recipient's mucous membranes with saliva, semen or vaginal secretions) for as long as they remain severely immunodeficient (CIII). Sexually active HCT recipients should avoid sexual practices that could result in oral exposure to feces (AIII).
2,746
Animal safety
Preventing pet-transmitted zoonotic infections Hematopoietic cell transplantation physicians should advise recipients and candidates undergoing conditioning therapy of the potential infection risks posed by pet ownership; however, they should not routinely advise Hematopoietic cell transplantation recipients and candidates need to be vigilant regarding maintenance of their pet's health (BIII). If the pet becomes ill, the owner should seek veterinary care promptly to minimize the possible transmission of the pet's illness to the owner. 747 Any pet that experiences diarrhea should be tested for infection (BIII) of Cryptosporidium, 2,746 Giardia species, 747 Salmonella and Campylobacter.
2,747 Owners should ensure that pets are up to date on recommended vaccinations (with the exception of live vaccines) (BIII). 755 Routine screening of healthy animals for zoonotic diseases is not recommended (DIII).
747
Feeding pets only high-quality commercial pet foods reduces the possibility of illness caused by spoiled or contaminated foods, thus reducing the possibility of transmitting illness from the pet to the HCT recipient. If eggs, poultry or meat products are given to the pet as supplements, they should be well cooked. Any dairy products given to pets should be pasteurized (BIII).
747 Pets should be prevented from drinking toilet bowl water, scavenging, hunting, eating other animals' feces and from having access to garbage (BIII).
If HCT recipients handle pets or clean cages, they should maintain hand hygiene with an alcohol-based hand gel or soap and water (preferred if hands are visibly soiled or after contact with feces). Adults should supervise hand disinfection of pediatric HCT recipients (BIII). HCT candidates and recipients should avoid contact with animal feces (BIII) to reduce the risk of toxoplasmosis, cryptosporidiosis, salmonellosis and campylobacteriosis, 747 and should not clean pet litter boxes or cages or dispose off animal waste (DIII).
1 If patients are unable to find assistance with these tasks, they should wear disposable gloves during such activities and wash their hands thoroughly afterward (BIII). Bird cage linings and cat litter should be cleaned regularly (for example, daily).
747 All persons, but particularly immunocompromised HCT candidates and recipients, should wear gloves whenever handling items contaminated with bird droppings (BIII), because droppings can be a source of C. neoformans, Mycobacterium avium or H. capsulatum.
747 To minimize potential exposure to Mycobacterium marinum, immunocompromised HCT recipients and candidates should not clean fish tanks (DIII). If this task cannot be avoided, patients should wear disposable gloves during such activities and disinfect their hands thoroughly afterward (BIII).
747,754
Hematopoietic cell transplantation candidates or recipients may also come into contact with animals in a medical setting. These animals are typically divided into three categories: service, therapy and visitation. 756 In most settings, access to service animals cannot legally be restricted. Animals are increasingly used as adjunctive therapy for patients with cancer and other chronic illnesses. Although many studies attest to the overall benefits of such 'therapy' or 'visitation' animals in various clinical settings, the risk of acquiring a zoonotic infection by immunosuppressed HCT candidates or recipients needs to be carefully considered and, thus, no recommendation can be given.
Preventing toxoplasmosis
Many cases of primary toxoplasmosis are acquired through eating undercooked meat. 747, 749 However, all HCT recipients and candidates, particularly those who are T. gondii seronegative, should be informed of the risks of contracting toxoplasmosis from ingestion of oocytes after contact with cat feces (BIII), although they need not be required to give away their cats (DII). In households with cats, litter boxes should not be placed in kitchens, dining rooms or other areas where food preparation and eating occur. 747 In addition, litter boxes should be cleaned daily by someone other than by the HCT recipient during the first 6 months after HCT and during periods of substantial immunosuppression to reduce the risk of transmitting toxoplasmosis to the HCT recipient (BIII). Daily litter box changes will minimize the risk of fecal transmission of T. gondii oocysts, because fecal oocysts require 41 day of incubation to become infectious. If HCT recipients perform this task during the first 6 months after HCT and during subsequent periods of substantial immunocompromise (for example, during GVHD, systemic steroid use or relapse of the underlying disease for which the transplant was performed), they should wear disposable gloves.
747 Gloves should be discarded after a single use (BIII). Soiled, dried litter should be disposed off carefully to prevent aerosolizing the T. gondii oocysts (BIII). Cat feces (but not litter) can be flushed down the toilet, although this is not recommended, as T. gondii oocysts are not consistently inactivated by sewage systems (DIII). Furthermore, persons who clean cat litter, particularly HCT recipients, should wash Guidelines for preventing infections in HCT D Yokoe et al their hands thoroughly with soap and water afterward to reduce their risk for acquiring toxoplasmosis (BIII).
Hematopoietic cell transplantation recipients and candidates with cats should keep their cats inside (BIII) and should not adopt or handle stray cats (DIII). Cats should be fed only canned or dried commercial food or wellcooked table food, not raw or undercooked meat, to eliminate the possibility of causing an illness that could be transmitted from the cat to the HCT recipient (BIII). Pet cats of HCT recipients do not need to be tested for toxoplasmosis (EII). Playground sandboxes should be kept covered when not in use to prevent cats from soiling them (BIII). HCT recipients and candidates undergoing conditioning therapy should avoid drinking raw goat's milk to decrease the risk of acquiring toxoplasmosis (DIII). Toxoplasmosis may also be acquired after contact with cat feces encountered while gardening.
Water and other beverage safety
Hematopoietic cell transplantation recipients should avoid walking, wading, swimming or playing in recreational water (for example, ponds or lakes) that is likely to be contaminated with Cryptosporidium, Escherichia coli O157:H7, 749,757-759 sewage or animal or human waste (DII). HCT recipients should also avoid swallowing such water (for example, while swimming), 2,757,759 as well as any water taken directly from rivers and lakes (EIII).
2,746
Water and other beverages may pose a risk to immunocompromised HCT candidates and recipients because of bacterial, viral and parasitic pathogens. HCT recipients should not use well water from private wells or from public wells in communities with limited populations (DIII) because tests for microbial contamination are performed too infrequently (for example, in certain locations, tests are performed p1 time/month) to detect sporadic bacterial contamination. However, drinking well water from municipal wells serving highly populated areas is regarded as being safe from bacterial contamination because the water is tested X2 times/day for bacterial contamination. If HCT recipients consume tap water, they should routinely monitor mass media (for example, radio, television or newspapers) in their area and immediately implement any boil-water advisories that might be issued for immunocompromised persons by state or local governments (BIII). A boil-water advisory means that all tap water should be boiled for 41 min before it is consumed.
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Although municipal tap water is generally safe, it may not be completely free of Cryptosporidium. Although limited data exist regarding the risks for and epidemiology of Cryptosporidium disease among HCT recipients, 761 HCT recipients should avoid possible exposures to Cryptosporidium (DIII) because this pathogen has been reported to cause severe, chronic diarrhea, malnutrition and death among other immunocompromised persons. 746, 762, 763 To eliminate the risk of Cryptosporidium exposure from tap water, HCT recipients can boil tap water for X1 min before consuming it (CIII).
746 Alternatively, they can use certain types of water filters or a home distiller to reduce their risk of exposure to Cryptosporidium 746 and other water-borne pathogens (CIII). If a home water filter is used, it should be capable of removing particles X1 mm in diameter, or should filter by reverse osmosis (for a list of filters certified under the NSF (National Sanitation Foundation) Standard 053 for cyst (that is, Cryptosporidium) removal, contact the NSF International consumer line or http:// www.nsf.org). However, the majority of these filters are not capable of removing smaller microbes (for example, bacteria or viruses), and therefore should be used only on properly treated municipal water. The majority of these devices are inappropriate for use on water from an unchlorinated private well to control viral or bacterial pathogens.
Bottled water can be consumed if it conforms to regional standards (for example, the FDA for the United States and Directive 80/777/EEC for the European Union) and has been processed to remove Cryptosporidium by one of three processes: reverse osmosis, distillation or 1-mm particulate absolute filtration. HCT recipients must contact the bottler directly to confirm that a specific bottled water has undergone one of these processes. The International Bottled Water Association can be contacted in the United States at 703 683-5213 from 0900 to 0170 hours EST (Eastern Standard Time) or anytime at their internet site (http:// www.bottledwater.org) to obtain contact information regarding water bottlers.
Patients can take other precautions in the absence of boil-water advisories to further reduce their risk for cryptosporidiosis. These extra precautions include avoiding fountain beverages and ice made from tap water at restaurants, bars and theaters; fruit drinks made from frozen concentrate mixed with tap water; and iced tea or coffee made with tap water. 746 Drinks that are likely to be Cryptosporidium safe for HCT recipients include nationally distributed brands of bottled or canned carbonated soft drinks; commercially packaged noncarbonated drinks that contain fruit juice; fruit juices that do not require refrigeration until after opening (for example, those that are stored unrefrigerated on grocery shelves); canned or bottled soda, seltzer or fruit drinks; steaming hot (4175 1F (80 1C)) tea or coffee; juices labeled as pasteurized and nationally distributed brands of frozen fruit juice concentrate that are reconstituted with water from a safe source.
705,746 HCT recipients should not drink nonpasteurized milk or fruit or vegetable juices (for example, apple cider or orange juice) to avoid infection with Brucella species, E. coli O157:H7, Salmonella species, Cryptosporidium and other pathogens (DII).
763-766

Food safety
Recommendations on food safety are based largely on the observations in the general population. Concern arising from the detection of potential pathogens in food has not been supported by documented evidence of such organisms as the source of opportunistic infections in immunocompromised persons. The potential benefit of food safety recommendations directed specifically toward HCT recipients must be weighed against the uncertain value of such Guidelines for preventing infections in HCT D Yokoe et al recommendations 767 and their potential to adversely affect patients' nutritional intake and/or quality of life.
Hematopoietic cell transplantation candidates and persons who prepare food for them after HCT should review general food safety practices (AIII) 768 and should be educated regarding additional food safety practices appropriate for HCT recipients. This review and education should be carried out before the conditioning regimen (that is, chemotherapy and radiation) begins (BIII). Adherence to these guidelines will decrease the risk for food-borne disease among HCT recipients.
Food safety practices appropriate for all persons Raw poultry, meat, fish and seafood should be handled on separate surfaces (for example, cutting board or counter top) from other food items. Persons preparing food should always use separate cutting boards or wash the board(s) with warm water and soap between cutting different food items (AIII). To prevent food-borne illnesses caused by Campylobacter jejuni and Salmonella enteritidis, which can cause severe and invasive infections among immunocompromised persons, 769 uncooked meat should not come in contact with other foods (DIII). After preparing raw poultry, meat, fish and seafood, and before preparing other foods, food handlers should wash their hands thoroughly in warm, soapy water. Any cutting boards, counters, knives and other utensils used should also be washed thoroughly in warm, soapy water (AIII). Food preparers should keep shelves, countertops, refrigerators, freezers, utensils, sponges, towels and other kitchen items clean (AIII). All fresh produce should be washed thoroughly under running water before serving (AIII). 768 Persons preparing food should follow published recommendations regarding safe food thawing (BIII).
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Persons cooking food for HCT recipients should follow established guidelines for monitoring internal cooking temperatures for meat, which is the only method for determining whether meat has been adequately cooked (AII). Different kinds of meat should be cooked to varying internal temperatures, all 4150 1F (66 1C) (AII). Specifically, food oversight agencies such as the US Department of Agriculture recommend that poultry be cooked to an internal temperature of 180 1F (82 1C). Other meat-and egg-containing casseroles and souffle´s should be cooked to an internal temperature of 4160 1F (71 1C). Cold foods should be stored at o40 1F (4 1C) and hot foods should be kept at 4140 1F (60 1C) (BIII). Food preparers should wash their hands before and after handling leftovers (AIII); use clean utensils and food-preparation surfaces (AIII); divide leftovers into small units and store in shallow containers for quick cooling (AII); refrigerate leftovers within 2 h of cooking (AII) or discard leftovers that were kept at room temperature for 42 h (AIII); reheat leftovers or heat partially cooked foods to 4165 1F (74 1C) throughout before serving (AII); bring leftover soups, sauces and gravies to a rolling boil before serving (AIII); and follow published guidelines for cold storage of food (AII). Leftover foods placed in the refrigerator should be dated and discarded after 72 h.
Additional food safety practices appropriate for HCT recipients Hematopoietic cell transplantation recipients' diets should be restricted before engraftment to decrease the risk of exposure to food-borne infections from bacteria, yeasts, molds, viruses and parasites. A low-microbial diet is recommended for HCT recipients before engraftment, 771, 772 although evidence for its efficacy in prevention of infection is lacking (CIII).
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Once HCT recipients have engrafted, they should follow a diet that balances the risk of acquiring food-borne illnesses with the importance of proper nutritional supplementation, as recommended below and outlined in Table 7 . This diet should be continued for 3 months after autologous HCT, and allogeneic HCT recipients should remain on this diet until all immunosuppressive drugs are discontinued and the patient has reached the milestone of receiving live virus vaccines. However, the HCT physician should have final responsibility for determining when the diet can be discontinued safely.
Hematopoietic cell transplantation recipients should not eat raw or undercooked meat, including beef, poultry, pork, lamb, venison or other wild game, or combination dishes containing raw or undercooked meat or sweetbreads from these animals (for example, sausages or casseroles) (EII). HCT recipients and candidates should only consume meat that is well done when they or their caretakers do not have direct control over food preparation (for example, when eating in a restaurant) (AI). Hot dogs and deli-style ready-to-eat meat should be avoided unless heated until steaming (AII).
Hematopoietic cell transplantation recipients should not consume raw or undercooked eggs or foods that might contain them (for example, certain preparations of hollandaise sauce, Caesar and other salad dressings, homemade mayonnaise and homemade eggnog) because of the risk of infection with S. enteritidis (EII).
774 HCT recipients should not consume raw or undercooked seafood (for example, oysters or clams) to prevent exposure to Vibrio species, viral gastroenteritis and Cryptosporidium parvum (EII).
769
Fruits and vegetables provide essential nutritional elements to HCT patients, but certain precautions should be taken to prevent acquisition of infection. In general, it may be helpful to remind patients of the adage 'If you can't peel or wash it, don't eat it'. Most infections from agricultural products are acquired either through contamination of the item while in the field or subsequent to harvesting during processing. Washing of fruits and vegetables in tap water is advisable even for those with skin or rinds, as well as for organic foods and prepackaged items labeled as 'pre-washed' (BIII). Such washing may prevent many contamination-related infections, but not all. HCT recipients should avoid fruits and vegetables that may confer a higher risk of infection, including raw vegetable sprouts (E. coli and Salmonella), fresh salsa and berries (EII).
Other food items that have been associated with foodborne outbreaks in the past and should therefore be avoided by HCT patients include unroasted raw nuts or nuts in the shell, miso products, raw grain products, nonpasteurized milk products (milk, cheese, yogurt), cheeses containing uncooked vegetables, cheeses with molds (that is, blue, Stilton, Roquefort and gorgonzola), soft cheeses (for example, brie and feta), smoked or pickled seafood, raw honey and tempe products (EII). To date, no evidence exists that there is a greater risk of acquiring infection from eating at a fast food restaurant than at a conventional sit-down restaurant. Several steps can be taken to ensure the safety of food consumed at such establishments (AIII): (1) Ask that food be freshly prepared (that is, avoid food that has been placed under heat lamps).
(2) Ask whether fruit juices are pasteurized. (3) Avoid any raw fruits and vegetables when dining out. (4) Ask for single-serving condiment packages (avoid the use of public self-serve condiment containers). (5) Avoid salad bars, delicatessens, buffets and smorgasbords and so on. (6) Set utensils on a napkin or clean tablecloth or placemat (rather than directly on the table). (7) If planning to take home leftovers, transfer the food directly to a box at the table. Similarly, although consumption of prepared food purchased from street vendors in industrialized countries has not been associated with infection, food preparation under stringent sanitary conditions cannot be guaranteed and therefore such food should be avoided (DIII); the same is true of food brought by others to gatherings such as potlucks or picnics.
The consumption of foods with 'active' or 'live' yeast cultures (probiotics) has been promoted as an effective means of preventing infections. Studies to date have not been definitive, but there is some support in literature for the possibility that consumption of probiotics reduces antibiotic-associated diarrhea 775 or genitourinary infections. 776 The use of probiotics has not been examined in the setting of HCT. Disseminated infection from probiotic administration has been reported in HCT patients, however, 777 and HCT recipients should avoid the use of probiotics (DIII). HCT candidates undergoing conditioning therapy and HCT recipients with neutropenia (that is, ANC o1000/ml 3 ) or during periods of substantial immunocompromise should also avoid exposure to naturopathic medicines that might contain molds (DIII).
778 HCT recipients wishing to take naturopathic medications are advised to use them only as prescribed by a licensed naturopathic physician working in consultation with the recipient's transplant and infectious disease physicians (CIII). Concern arising from the detection of potential pathogens in food has not been supported by documented evidence of such organisms as the source of opportunistic infections in immunocompromised persons. The potential benefit of food safety recommendations directed specifically toward HCT recipients must be weighed against the uncertain value of such recommendations 767 and their potential to adversely affect patients' nutritional intake and/or quality of life. a Though not completely risk free, the risk of contracting foodborne illness from cooked soft cheeses is low. b Shelf-stable refers to unopened canned, bottled or packaged food products that can be stored before opening at room temperature; container may require refrigeration after opening. c Aseptically packaged, shelf-stable tofu and pasteurized tofu do not need to be boiled. Non-pasteurized tofu must be cut into 1-inch cubes or smaller, and boiled a minimum of 5 min in water or broth before eating or using in recipes. d Rinse under clean, running water before use, including produce that is to be cooked or peeled (such as bananas, oranges and melon). e Bring tap water to a rolling boil and boil for 15-20 min. Store boiled water in the refrigerator. Discard water not used within 48 h (2 days). f Recommend using boiled or bottled water if using a water service other than city water service. Please see 'Water Safety Guidelines' in 'Food Safety Guidelines'. g See 'Water Safety Guidelines' in 'Food Safety Guidelines' for approved bottled water treatments. h Honey products are not allowed for any child aged o1 year and not allowed for children with SCID syndrome until 9 months post transplant.
Travel safety
For HCT recipients, particularly allogeneic recipients who are chronically immunosuppressed, travel to developing countries can pose substantial risks of exposure to opportunistic pathogens. HCT recipients should not plan travel to developing countries without consulting their physicians (EIII), and should not undertake such travel until the period of severe immunosuppression has resolved. Generally, allogeneic recipients should not plan travel to developing countries for 6-12 months after HCT, and should refrain from travel in the setting of immunosuppressive treatment for GVHD. Autologous recipients can travel to developing countries 3-6 months after HCT if their HCT providers agree that this is safe and appropriate.
Hematopoietic cell transplantation recipients should be educated regarding strategies to minimize the risk of acquiring infections while traveling. Selected strategies include the following:
HCT recipients should obtain updated, detailed health information for international travelers from health organizations (AIII).
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'Adventure' travel (for example, kayaking, participating in triathlons) has been associated with epidemic infections (such as leptospirosis), and should be avoided (DIII).
780-782
Air travel is generally safe, although it may rarely be associated with acquisition of respiratory illnesses (for example, influenza, tuberculosis, measles).
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HCT recipients should use techniques such as social distancing and hand hygiene to avoid infections from other passengers in close proximity who exhibit respiratory symptoms (BIII). Cruise ships are generally considered to be safe, but may be associated with acquisition of gastrointestinal (for example, norovirus) and Legionella infections. HCT recipients should be fastidious about washing hands with soap and water frequently while on cruises and should promptly report any symptoms that may arise to their transplant team (AII). Food safety is of paramount importance while traveling to developing countries. HCT recipients should avoid consuming (DIII) raw fruits and vegetables; tap water or any potentially untreated or contaminated water; ice made from tap water or from any potentially contaminated water; nonpasteurized milk or any nonpasteurized dairy products; fresh fruit juices, food and drinks from street vendors; and raw or undercooked eggs. Steaming hot foods, fruits peeled by oneself, bottled and canned processed drinks and hot coffee or tea are probably safe. 784 Travelers should plan for treating their drinking water while in developing countries. If bottled water is not available, boiling is the best method for making water safe. However, if boiling of water is not feasible, the traveler should carry supplies for disinfecting water (for example, commercially available iodine disinfection tablets or a portable water filter) (BIII). 784, 785 As referenced in the food safety section, water disinfection does not mitigate the risk of cryptosporidiosis and viral infections.
Antimicrobial prophylaxis for traveler's diarrhea is not recommended routinely for HCT recipients traveling to developing countries (DIII). However, HCT physicians who wish to provide prophylaxis to HCT recipients who are traveling can prescribe a fluoroquinolone (for example, ciprofloxacin) (Appendix 1) (CIII). Some clinicians recommend using bismuth subsalicylate to prevent traveler's diarrhea in adults. 784 However, no data were found regarding safety and efficacy among HCT recipients, and salicylates are not recommended for use among persons younger than 18 years of age because salicylates are associated with Reye's syndrome. 784 The immunization status of HCT recipients should be assessed and their vaccinations updated as needed before travel (Table 5) . 784 Influenza chemoprophylaxis with oseltamivir or zanamivir (depending on the circulating strain and susceptibilities) can be used for immunocompromised HCT recipients who could be exposed to influenza while traveling (CIII), but travelers should be vigilant with regard to the risk of pandemic influenza or severe acute respiratory syndrome.
